PPAR-gamma agonists: shifting attention from the belly to the heart?

Arterioscler Thromb Vasc Biol. 2004 May;24(5):798-800. doi: 10.1161/01.ATV.0000127311.38703.1f.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Adipocytes / drug effects
  • Adipocytes / metabolism
  • Cardiotonic Agents / pharmacology*
  • Cardiotonic Agents / therapeutic use
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Carotid Artery Diseases / etiology
  • Carotid Artery Diseases / prevention & control
  • Carotid Artery, Common / drug effects
  • Carotid Artery, Common / pathology
  • Diabetes Mellitus, Type 2 / drug therapy
  • Humans
  • Insulin Resistance
  • Metabolic Syndrome / drug therapy*
  • Models, Biological
  • Receptors, Cytoplasmic and Nuclear / agonists*
  • Receptors, Cytoplasmic and Nuclear / physiology
  • Thiazolidinediones / pharmacology*
  • Thiazolidinediones / therapeutic use
  • Transcription Factors / agonists*
  • Transcription Factors / physiology

Substances

  • Cardiotonic Agents
  • Receptors, Cytoplasmic and Nuclear
  • Thiazolidinediones
  • Transcription Factors